Clinical Trial Update: Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cisplatin, bevacizumab, and intensity-modulated radiation therapy in stage III/IV head and neck cancer has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-08-18